Keyphrases
Denmark
100%
National Cohort Study
90%
Pneumocystis Jirovecii
85%
Endocarditis
81%
Infective Endocarditis
71%
Brain Abscess
47%
Meningitis
41%
Confidence Interval
34%
Unfavorable Outcome
33%
Left-sided Infective Endocarditis
31%
Patients with Hematological Malignancies
31%
Oral Antibiotics
29%
Antifungal Therapy
29%
Varicella Zoster Virus
26%
Oral Treatment
25%
Lung Transplantation
23%
Stem Cell Transplant Recipients
23%
Observational Cohort Study
23%
Herpes Simplex Virus 2 (HSV-2)
21%
Invasive Aspergillosis
21%
Viral Meningitis
21%
Oncology Patients
20%
Antibiotic Treatment
19%
Risk Factors
19%
Glasgow Outcome Scale
19%
Central Nervous System Infections
18%
Renal Transplant Recipients
18%
Voriconazole
18%
Microorganisms
17%
COVID-19
17%
Viral
17%
Bacteremia
16%
S. Hominis
16%
Pneumocystis Carinii
16%
All-cause Mortality
15%
Antibiotics
15%
Intravenous Antibiotics
15%
Community-acquired Bacterial Meningitis
15%
Randomized Controlled Trial
15%
Cystic Fibrosis
15%
Population-based Case-control Study
15%
Antifungal Prophylaxis
15%
Population-based Cohort Study
15%
Intravenous Treatment
15%
Prospective Cohort Study
15%
Study Registry
15%
Encephalitis
15%
Cerebrospinal Fluid
14%
Clinical Characteristics
14%
Clinical Features
14%
Medicine and Dentistry
Cohort Analysis
94%
Infective Endocarditis
51%
Endocarditis
46%
Meningitis
43%
Infection
41%
Brain Abscess
40%
Pneumocystis Jirovecii
38%
Human Immunodeficiency Virus
29%
Diagnosis
29%
Bacterial Meningitis
24%
Antifungal Therapy
23%
Lung Transplantation
23%
Symptom
22%
Virus Meningitis
22%
COVID-19
21%
Antifungal Agent
21%
Central Nervous System Infection
20%
Herpes Simplex Virus 2
18%
Antibiotics
18%
Voriconazole
18%
Hematologic Malignancy
17%
Antibiotic Therapy
17%
Varicella Zoster Virus
17%
Invasive Aspergillosis
17%
Severe Acute Respiratory Syndrome Coronavirus 2
17%
Immunocompromised Patient
16%
Cerebrospinal Fluid
15%
Stem Cell Transplant
15%
Kidney Graft
15%
Hematology
15%
Case-Control Study
15%
Mucormycosis
15%
Cohort Study
15%
Cystic Fibrosis
15%
Glasgow Outcome Scale
15%
Leukocyte
13%
Magnetic Resonance Imaging
12%
Heart Surgery
12%
Cohort Effect
11%
Surgery
11%
Clinical Feature
11%
Debridement
11%
Enterovirus
11%
Amphotericin B
10%
Prevalence
10%
Disease
10%
Lumbar Puncture
9%
Prognostic Factor
9%
Adverse Event
9%
Encephalitis
9%
Pharmacology, Toxicology and Pharmaceutical Science
Cohort Study
85%
Bacterial Endocarditis
65%
Endocarditis
58%
Meningitis
51%
Infection
33%
Bacterial Meningitis
33%
Antibiotics
31%
Antifungal Agent
31%
Virus Meningitis
29%
Antibiotic Agent
24%
Invasive Aspergillosis
19%
Voriconazole
18%
Central Nervous System Infection
18%
Herpes Simplex Virus 2
17%
Immunocompromised Patient
16%
Varicella Zoster Virus
15%
Randomized Controlled Trial
15%
Amphotericin B
14%
Bacteremia
14%
Disease
13%
Streptococcus
13%
Glasgow Outcome Scale
12%
Penicillin G
11%
All Cause Mortality
11%
Linezolid
10%
Rifampicin
10%
Adverse Event
10%
Clinical Feature
10%
HIV
9%
Leukemia
9%
Symptom
9%
SARS Coronavirus
9%
Piperacillin Plus Tazobactam
9%
Pharmacodynamics
9%
Infectious Agent
9%
Encephalitis
9%
Prospective Cohort Study
8%
Pharmacokinetics
8%
Hydroxychloroquine
7%
Azithromycin
7%
Herpes Zoster Oticus
7%
Intrathecal
7%
Mucormycosis
7%
Streptococcus Group A
7%
Herpes Zoster Encephalitis
7%
Cytomegalovirus
7%
Candidiasis
7%
Acute Myeloid Leukemia
7%
Basal Cell Carcinoma
7%
Cystic Fibrosis
7%
